Analyst Ratings For NMC Health PLC (LON:NMC)
Today, JPMorgan Chase & Co. raised its price target on NMC Health PLC (LON:NMC) to GBX 4,060 per share.
There are 2 Hold Ratings, 1 Strong Buy Ratings, 1 Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on NMC Health PLC (LON:NMC) is Buy with a consensus target price of GBX 4,337.75 per share, a potential .
Some recent analyst ratings include
- 8/20/2018-NMC Health PLC (LON:NMC) had its top pick rating reiterated by Barclays
- 2/22/2017-NMC Health PLC (LON:NMC) had its Sector Perform rating reiterated by Scotiabank
- 8/30/2016-NMC Health PLC (LON:NMC) had its Buy rating reiterated by Numis Securities
About NMC Health PLC (LON:NMC)
NMC Health Plc provides healthcare services in the United Arab Emirates, Spain, and internationally. The company operates through two businesses, NMC Healthcare and NMC Trading. It owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers. The company has developed specialized verticals covering multi-specialty care, maternity and fertility, long-term and home care, operations and management, and distribution services. It is also involved in the distribution of pharmaceutical products, medical equipment, medical consumables and devices, education and office supplies, veterinary products, cosmetics, IT products, and rehab supplies, as well as consumer products, including personal care, food and beverages, household care, and home improvement products. The company was founded in 1975 and is based in London, the United Kingdom.
Recent Trading Activity for NMC Health PLC (LON:NMC)
Shares of NMC Health PLC closed the previous trading session at 136,00 up +16,00 0,39 % with shares trading hands.